572 related articles for article (PubMed ID: 28636886)
1. SIRT1 enzymatically potentiates 1,25-dihydroxyvitamin D
Sabir MS; Khan Z; Hu C; Galligan MA; Dussik CM; Mallick S; Stone AD; Batie SF; Jacobs ET; Whitfield GK; Haussler MR; Heck MC; Jurutka PW
J Steroid Biochem Mol Biol; 2017 Sep; 172():117-129. PubMed ID: 28636886
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol potentiates vitamin D and nuclear receptor signaling.
Dampf Stone A; Batie SF; Sabir MS; Jacobs ET; Lee JH; Whitfield GK; Haussler MR; Jurutka PW
J Cell Biochem; 2015 Jun; 116(6):1130-43. PubMed ID: 25536521
[TBL] [Abstract][Full Text] [Related]
3. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.
Kim S; Shevde NK; Pike JW
J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825
[TBL] [Abstract][Full Text] [Related]
4. Stimulation of Sirt1-regulated FoxO protein function by the ligand-bound vitamin D receptor.
An BS; Tavera-Mendoza LE; Dimitrov V; Wang X; Calderon MR; Wang HJ; White JH
Mol Cell Biol; 2010 Oct; 30(20):4890-900. PubMed ID: 20733005
[TBL] [Abstract][Full Text] [Related]
5. Curcumin: a novel nutritionally derived ligand of the vitamin D receptor with implications for colon cancer chemoprevention.
Bartik L; Whitfield GK; Kaczmarska M; Lowmiller CL; Moffet EW; Furmick JK; Hernandez Z; Haussler CA; Haussler MR; Jurutka PW
J Nutr Biochem; 2010 Dec; 21(12):1153-61. PubMed ID: 20153625
[TBL] [Abstract][Full Text] [Related]
6. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation.
Raval-Pandya M; Freedman LP; Li H; Christakos S
Mol Endocrinol; 1998 Sep; 12(9):1367-79. PubMed ID: 9731705
[TBL] [Abstract][Full Text] [Related]
7. Crosstalk between the peroxisome proliferator-activated receptor γ (PPARγ) and the vitamin D receptor (VDR) in human breast cancer cells: PPARγ binds to VDR and inhibits 1α,25-dihydroxyvitamin D3 mediated transactivation.
Alimirah F; Peng X; Yuan L; Mehta RR; von Knethen A; Choubey D; Mehta RG
Exp Cell Res; 2012 Nov; 318(19):2490-7. PubMed ID: 22884583
[TBL] [Abstract][Full Text] [Related]
8. Antagonistic effects of transforming growth factor-beta on vitamin D3 enhancement of osteocalcin and osteopontin transcription: reduced interactions of vitamin D receptor/retinoid X receptor complexes with vitamin E response elements.
Staal A; Van Wijnen AJ; Desai RK; Pols HA; Birkenhäger JC; Deluca HF; Denhardt DT; Stein JL; Van Leeuwen JP; Stein GS; Lian JB
Endocrinology; 1996 May; 137(5):2001-11. PubMed ID: 8612541
[TBL] [Abstract][Full Text] [Related]
9. Salt concentration determines 1,25-dihydroxyvitamin D3 dependency of vitamin D receptor-retinoid X receptor--vitamin D-responsive element complex formation.
Kimmel-Jehan C; Jehan F; DeLuca HF
Arch Biochem Biophys; 1997 May; 341(1):75-80. PubMed ID: 9143355
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional control of intestinal cytochrome P-4503A by 1alpha,25-dihydroxy vitamin D3.
Thummel KE; Brimer C; Yasuda K; Thottassery J; Senn T; Lin Y; Ishizuka H; Kharasch E; Schuetz J; Schuetz E
Mol Pharmacol; 2001 Dec; 60(6):1399-406. PubMed ID: 11723248
[TBL] [Abstract][Full Text] [Related]
11. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
[TBL] [Abstract][Full Text] [Related]
12. Stat1-vitamin D receptor interactions antagonize 1,25-dihydroxyvitamin D transcriptional activity and enhance stat1-mediated transcription.
Vidal M; Ramana CV; Dusso AS
Mol Cell Biol; 2002 Apr; 22(8):2777-87. PubMed ID: 11909970
[TBL] [Abstract][Full Text] [Related]
13. Carboxylic ester antagonists of 1alpha,25-dihydroxyvitamin D(3) show cell-specific actions.
Herdick M; Steinmeyer A; Carlberg C
Chem Biol; 2000 Nov; 7(11):885-94. PubMed ID: 11094341
[TBL] [Abstract][Full Text] [Related]
14. Heterodimer requirement for gene regulation by Vitamin D in variant OK cells.
Koszewski NJ; Rowan A
Steroids; 2003 Apr; 68(4):307-14. PubMed ID: 12787891
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D3 transactivates the zinc and manganese transporter SLC30A10 via the Vitamin D receptor.
Claro da Silva T; Hiller C; Gai Z; Kullak-Ublick GA
J Steroid Biochem Mol Biol; 2016 Oct; 163():77-87. PubMed ID: 27107558
[TBL] [Abstract][Full Text] [Related]
16. Hairless modulates ligand-dependent activation of the vitamin D receptor-retinoid X receptor heterodimer.
Chuma M; Endo-Umeda K; Shimba S; Yamada S; Makishima M
Biol Pharm Bull; 2012; 35(4):582-7. PubMed ID: 22466564
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D receptor deficit induces activation of renin angiotensin system via SIRT1 modulation in podocytes.
Chandel N; Ayasolla K; Wen H; Lan X; Haque S; Saleem MA; Malhotra A; Singhal PC
Exp Mol Pathol; 2017 Feb; 102(1):97-105. PubMed ID: 28069388
[TBL] [Abstract][Full Text] [Related]
18. Phytoestrogen regulation of a Vitamin D3 receptor promoter and 1,25-dihydroxyvitamin D3 actions in human breast cancer cells.
Wietzke JA; Welsh J
J Steroid Biochem Mol Biol; 2003 Feb; 84(2-3):149-57. PubMed ID: 12710998
[TBL] [Abstract][Full Text] [Related]
19. Resistance of HBL100 human breast epithelial cells to vitamin D action.
Agadir A; Lazzaro G; Zheng Y; Zhang XK; Mehta R
Carcinogenesis; 1999 Apr; 20(4):577-82. PubMed ID: 10223184
[TBL] [Abstract][Full Text] [Related]
20. Interaction of two novel 14-epivitamin D3 analogs with vitamin D3 receptor-retinoid X receptor heterodimers on vitamin D3 responsive elements.
Verlinden L; Verstuyf A; Quack M; Van Camp M; Van Etten E; De Clercq P; Vandewalle M; Carlberg C; Bouillon R
J Bone Miner Res; 2001 Apr; 16(4):625-38. PubMed ID: 11315990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]